Foundation / Corporation
Canadian Institutes of Health Research (CIHR), International Development Research Centre (IDRC), Israel Science Foundation (ISF), Azrieli Foundation
Grants to Canada and Israel nonprofits, for-profits, IHEs, and research hospitals for collaborative cutting-edge research projects in the field of biomedical science. Applicants must complete registrations by January 16. This call for proposals is aimed at basic biomedical sciences, with the intent to develop capacity and further the knowledge base in low- and middle-income countries.
The organizations funding this Program support the search for breakthroughs in health sciences that have the potential to bring about enduring changes across the globe, including in developing regions. The Program will support world-class research teams co-led by Canadian and Israeli investigators. The teams will be expected to integrate researchers from low and middle income countries (see Appendix A for list of eligible countries) to further their scientific capacity. In their capacity as collaborators or trainees, researchers in eligible countries will contribute to and benefit from their involvement in the Initiative.
Teams are encouraged to integrate sex and gender perspectives into their research, including where relevant Sex- and Gender-Based Analysis (SGBA). SGBA is an approach that systematically examines sex-based (biological) and gender-based (socio-cultural) differences, to promote rigorous science that is sensitive to sex and gender and has the potential to expand our understanding of health determinants for all people.
The fourth call of this program supports biomedical sciences with special emphasis on new frontiers in neurobiology.
Potential topics may include, but are not limited to the following:
-Molecular, genetic and epigenetic basis of neurological diseases
-Regenerative medicine in brain disease
-Cellular and molecular basis of cognition
-Modeling brain function
-Imaging of neural processes
-Novel technologies in neurobiology
-Randomized Controlled Trials
Clinical Trials will NOT be funded through this Funding Opportunity. However, the use of randomization in basic biomedical research studies is accepted.
This funding opportunity is expected to:
-Advance research and discovery in the biomedical sciences;
-Encourage scientific collaboration between Canadian and Israeli researchers and trainees; and
-Build capacity in biomedical science and foster scientific relations and collaborations with researchers and trainees in low and middle income countries.
General CIHR Policies:
This funding opportunity will comply fully with the policies and guidelines as outlined in the Access to Information Act, Privacy Act and Tri-Agency Open Access Policy on Publications. Applicants, whose proposed research will involve Aboriginal People, please consult Ethics of Health Research Involving First Nations, Inuit and Métis People. Information collected by CIHR may be shared as described in the Conflict of Interest and Confidentiality Policy of the Federal Research Funding Organizations.
Conditions of Funding:
-The applicant must consent to the use and disclosure of full application and nominative information for relevance review and funding decisions at the time of application.
-The Canadian and Israeli components of each successful application will be funded separately.
-IDRC will issue a Grant Agreement to the lead Canadian institution and ISF will issue a grant agreement to the lead Israeli institution. Each agency's respective policies will apply.
-Grants will be managed by eligible institutions that employ and support the role of the Principal Investigator in Canada/Israel at the time of application.
-Canadian applicants who are successful in this competition are strongly encouraged to actively participate in peer review, and as members of the CIHR College of Reviewers, when invited.
Applications will be assessed for scientific excellence using the following criteria:
1. Scientific merit
-Originality of the proposed research, in terms of the hypotheses/research questions addressed, novel technology/methodology, and/or novel applications of current technology/methodology.
-Potential for the creation of new knowledge.
-Potential for impact of the research.
-Clarity of the research question.
-Completeness of the literature review and relevance to study design/research plan.
-Clarity of rationale for the research approach and methodology.
-Appropriateness of the research design and methods.
-Where relevant, evidence of how sex and/or gender considerations will be taken up in the research approach (as written in the sex and/or gender section of the application).
-Feasibility of the research approach (including project timeline, preliminary data where appropriate, etc.).
-Anticipation of difficulties that may be encountered in the research and plans for management.
2. Experience and achievements of the applicants
-Qualifications of the applicant(s), including training, experience and independence (relative to career stage).
-Experience of the applicant(s) in the proposed area of research and with the proposed methodology.
-Expertise of the applicant(s), as demonstrated by scientific productivity over the past five years (publications, books, grants held, etc.). Productivity should be considered in the context of the norms for the research area, applicant experience and total research funding of the applicant.
-Ability to successfully and appropriately disseminate research findings, as demonstrated by knowledge translation activities (publications, conference presentations, briefings, media engagements, etc.).
3. Collaboration within the project
-Potential for synergy between the collaborating researchers (e.g. Plans for exchange of researchers and trainees).
-Clarity of rationale for integration of collaborators in low and middle income countries and expected benefits.
-Potential for sustainability of international relationships.
4. Environment and Infrastructure for the Research
-Availability and accessibility of personnel, facilities and infrastructure required to conduct the research.
-Suitability of the environment to conduct the proposed research.
-Suitability of the environment (milieu, project and mentors) for the training of personnel (if applicable).
GrantWatch ID#: 177772
The current competition will fund up to six teams.
The maximum amount per project that can be requested by the Israeli PA from ISF is up to NIS 1,540,000 over 3 years.
The maximum amount per project that can be requested by the Canadian PA from IDRC is up to CAD $670,000 over 3 years.
Projects will be funded over 3 years.
Research hospitals, universities, colleges and for-profit and not-for-profit organizations are eligible to manage the Canadian grant.
For your application to be eligible:
1. Each team must include only two Principal Applicants (PAs), one in Canada and one in Israel.
2. All other researchers (including those from low and middle income countries) must participate as collaborators.
3. Applicants must include a Collaboration Plan for integrating researchers in low and middle income countries and establishing long-term scientific relationships with them.
4. As a minimum eligibility requirement, all proposals must support at least one of the following activities aimed at supporting capacity and scientific relationships:
-Significant training opportunities such as scientific workshops, graduate training in Canada or Israel, or summer schools benefiting researchers/trainees in eligible low and middle income countries;
-Inclusion of trainees from low and middle income countries in the carrying out of the research; and/or
-Inclusion of established researchers from low and middle income countries in the carrying out of the research.
-Each PA can only submit and/or participate on one application in the competition.
-In addition to submitting the application to CIHR, the Israeli PA must register on the ISF online system, as described in the ISF specific guidelines.
-Principal Applicants from either Canada or Israel are not eligible to hold more than one active grant of this joint program at any given time.
The application process for this funding opportunity consists of two steps: registration and application. Registrations are due January 16, 2018, and applications are due February 13, 2018.
Note: The Canadian and Israeli PAs will submit one joint application through ResearchNet. In addition, the Israeli PA is responsible for submitting a separate, administrative application to ISF.
Further instructions regarding ISF requirements.
Detailed guidelines for submission are published on CIHR’s Funding Opportunity database:
To complete your registration, follow the instructions in the Grants - Registration Guidelines along with any additional instructions found below under "Specific Instructions”:
To complete your application, follow the instructions in the Grants – Application Guidelines along with any additional instructions found below under "Specific Instructions”:
All participants listed (other than Collaborators) will require a CIHR PIN:
The Canadian PA and the Israeli PA must create a Registration CV through the Canadian Common CV website. All other participants are not required to create a CV at this stage:
CCV Frequently Asked Questions for CIHR Applicants:
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Submit an application through ResearchNet:
For all inquiries please contact:
CIHR Contact Centre
Toll Free: 1-888-603-4178
Israeli applicants should direct their questions to ISF:
Scientific Director Special Programs
Israel Science Foundation
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon